Riadh Jemaa^1-3, Rabie Razgallah^1,4, Lamia Rais¹, Imed Ben Ghorbel¹, Moncef Feki^2,3 and Amani Kallel³*

¹Tunisian Association for Study and Research on Atherosclerosis (ATERA), Tunisia
²Research Laboratory LR99ES11, Faculty of Medicine of Tunis El Manar University, Tunisia
³Biochemistry Department, La Rabta Hospital, Tunis, Tunisia
⁴Dacima Consulting, Tunisia

*Corresponding Author: Amani Kallel, Biochemistry Department, La Rabta Hospital, Tunis, Tunisia.

Received: September 20, 2024; Published: November 12, 2024

Abstract

Background: The purpose of this study was to describe the prevalence of diabetes mellitus and pre-diabetes and their associated risk factors among the Tunisian population.

Methods: The ATERA-survey was a nationally representative, cross-sectional study conducted between January 2016 and Mars 2019. Sociodemographic and behavioral characteristic data were collected by face-to-face interviews during a door-to-door visit.

Results: 10576 participants (4642 men and 5934 women) aged 25-75 years completed an interview and medical examination. The overall prevalence of diabetes was estimated to be 23.0 % (95% CI, 22.2% - 23.8%) of which 16.6% (95% CI, 14.8% -18.3%) were previously known cases of diabetes and 6.4% (4.5% - 8.2%) were newly detected. The prevalence among men was 23.8% (95% CI, 22.9% -24.6%) and among women was 22.30% (95% CI, 21.5% - 23.0%), as well as 24.5% (95% CI, 22.6% -26.4%) and 18.7% (95% CI, 15.3% - 22%) in urban and rural residents, respectively. In addition, the prevalence of pre-diabetes was estimated to be 21.8% (95% CI, 20.1% - 23.5%) in Tunisian adults; 20.9% (95% CI, 18.4% - 23.5%) in men and 22.4% (95% CI, 20.2% - 24.78%) in women. The prevalence of diabetes and pre-diabetes was higher in older age groups and in persons living in economically developed regions.

Conclusions: Our results indicate that diabetes has become a major public health problem in Tunisia. Urgent measures are needed to prevent diabetes and its related complications.

 Keywords: Diabetes; Pre-Diabetes, Prevalence; Risk Factors; Epidemiology; Tunisia

References

1. Ferrara A. “Increasing prevalence of gestational diabetes mellitus; a public health perspective”. Diabetes Care 30 (2007): S141-S146.
2. Pouya S., et al. “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the international Diabetes Federation Diabetes Atlas, 9^th edition”. Diabetes Research and Clinical Practice 157 (2019): 107843.
3. Nathan DM., et al. “Impaired fasting glucose and impaired glucose tolerance: implications for care”. Diabetes Care 30 (2007): 753-759.
4. Gossain VV and Aldasouqi S. “The challenge of undiagnosed pre-diabetes, diabetes and associated cardiovascular disease”. International Journal of Diabetes Mellitus 2 (2010): 43-46.
5. Hostalek U. “Global epidemiology of pre-diabetes-present and future perspectives”. Clinical Diabetes and Endocrinology (2019): 5.
6. Sicree R., et al. “Diabetes and impaired glucose tolerance. In; Gan D, ed. Diabetes Atlas”. Belgium: International Diabetes Federation (2006): 22-37.
7. Bouguerra R., et al. “The global diabetes pandemic: the Tunisian experience”. European Journal of Clinical Nutrition 61 (2007): 160-65.
8. Ben Romdhane H., et al. “Prevalence of diabetes in northern African countries: the case of Tunisia”. BMC Public Health 14 (2014): 86.
9. Kallel A., et al. “The ATERA Survey: Study Design and Main Results”. Acta Scientific Medical Sciences 8 (2024): 23-28.
10. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report on a WHO Consulting on Obesity. World Health Organisation: Genova (207). who/NUT/NCD/98.1.
11. Alderman M., et al. “World Health Organization-international Society of Hypertensison guidelines for the management of hypertension, Blood Press 89 (1999): 43.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. “Executive summary of the third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii)”. JAMA 285 (2001): 2486-2497.
13. Friedwald WT., et al. “Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, without use of the preparative ultracentrifuge”. Clinical Chemistry 18 (1972): 499-502.
14. Al-Daghri NM., et al. “Diabetes mellitus type 2 and other chronic non-communicable dieigue seases in the central region, Saudia Arabia (Riyadh cohort 2); a decade of an epidemic”. BMC Medicine 20 (2011): 76.
15. Al-Sinani S., et al. “Familial clustering of type 2 diabetes among Omanis”. Oman Medical Journal 29 (2014): 51-54.
16. Basit A., et al. “NDSP Members. Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP)”. BMJ Open 8 (2018): e020961.
17. Hannadeh RR. “Noncommunicale diseases among the Bahraini population: a review”. Eastern Mediterranean Health Journal 6 (2000): 1091-1097.
18. Channanath AM., et al. “State of diabetes, hypetension, and comordidity in Kuwait: showcasing the trends as seen in native versus expatriate populations”. Diabetes Care 36 (2013): e75.
19. Malik M., et al. “Glucose intolerance and associated factors in the multi-ethnic population of the United Arab Emirates; results of a nationally survey”. Diabetes Research and Clinical Practice 69 (2005): 188-195.
20. Wan Nazaimoon WM., et al. “Prevalence of diabetes in Malaysia and usefulness of HbA1c as a diagnostic criterion”. Diabetes Medications 30 (2013): 825-828.
21. Abduelkarem AR., et al. “Prognostic indices for hospital mortality among Liban diabetics patients”. Practical Diabetes International 27 (2010): 392-395.
22. Ajlouni K., et al. “An increase in prevalence of diabetes mellitus in Jordan over 10 years”. Journal of Diabetes and its Complications 22 (2008): 317-324.
23. Hussam Zayed. “Egypt’s health ministry survey; 62 percent population overweight, 17 percent diabetic (2014).
24. Bener A., et al. “Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar”. Diabetes Research and Clinical Practice 84 (2009): 99-106.
25. Albache N., et al. “Epidemiology of type 2 diabetes mellitus in Aleppo, Syria”. Journal of Diabetes 2 (2010): 85-91.
26. Zaouiet S., et al. “Epidemiology of diabetes in urban and rural regions of Tlemcen Western Algeria”. Sante 17 (2007): 15-21.
27. Soriguer F., et al. “Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Diabetes Study”. Diabetologia 55 (2012): 88-93.
28. Menke A., et al. “Prevalence of and trends in diabetes among adults in the United states, 1988-2012”. JAMA 314 (2015): 1021-1029.
29. Ujcic-Voortman JK., et al. “Diabetes prevalence and risk factors among ethnic minorities”. European Journal of Public Health 19 (2009): 511-515.
30. Xu Y., et al. “Prevalence and control of diabetes in Chinese Adults”. JAMA 310 (2013): 948-959.
31. Golozar A., et al. “Diabetes mellitus and its correlates in an Iranian adult population”. Plot One 6 (2011): e26725.
32. Endris T., et al. “Prevalence of Diabetes Mellitus, Prediabetes and Its Associated Factors in Dessie Town, Northeast Ethiopia: A Community-Based Study”. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 12 (2019): 2799-2809.
33. Aekplakorn W., et al. “Prevalence and management of diabetes and associated risk factors by regions of Thailand: Third National Health Examination Survey 2004”. Diabetes Care 30 (2007): 2007-2012.
34. Zghebi SS., et al. “Examining trends in type 2 diabetes incidence, prevalence and mortality in the UK between 2004 and 2014”. Diabetes, Obesity and Metabolism 19 (2017): 1537-1545.
35. Meiloud G., et al. “Type 2 diabetes in Mauritania: prevalence of the undiagnosed diabetes, influence of family history and maternal effect”. Primary Care Diabetes 7 (2013): 19-24.
36. Duncan BB., et al. “The burden of diabetes and hyperglycemia in Brazil: a global burden of disease study 2017”. Population Health Metrics 1 (2020): 9.
37. World Bank Data: Diabetes prevalence (% of population ages 20 to 79) (2020).
38. Lerman IG., et al. “The Prevalence of Diabetes and Associated Coronary Risk Factors in Urban and Rural Older Mexican Populations”. JAGS 46 (1998): 1387-1395.
39. Kalyani RR., et al. “Diabetes and aging unique considerations and goals of care”. Diabetes Care 40 (2017): 440-443.
40. Ekoe JM., et al. “Screening for diabetes in adults”. Canadian Journal of Diabetes 42 (2018): S16-S19.
41. Alberti KG., et al. “Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation”. Diabetic Medicine 23 (2016): 469-480.
42. Mao W., et al. “Complications of diabetes in China: health system and economic implications”. BMC Public Health 19 (2019): 269.
43. Wang R., et al. “The prevalence of pre-diabetes and diabetes and their associated factors in Northeast China; a cross-sectional study”. Scientific Reports 9 (2019): 2513.
44. Akter S., et al. “Prevalence of diabetes and pre-diabetes and their risk factors among Bangladeshi adults: a nationwide survey”. Bull world Health Organ 92 (2014): 204-213A.
45. Hu D., et al. “Prevalence and risk factors for type 2 diabetes mellitus in the Chinese adult population: the inter ASIA Study”. Diabetes Research and Clinical Practice 84 (2009): 288-295.
46. Deng Y and Scherer PE. “Adipokines as novel biomarkers and regulators of the metabolic syndrome”. Annals of the New York Academy of Sciences 1212 (2010): E1-E19.
47. Latt TS., et al. “Measurement of diabetes, prediabetes and their associated risk factors in Myanmar 2014”. Diabetes, Metabolic Syndrome and Obesity 12 (2019): 291-298.
48. Basit A., et al. “Prevalence of diabetes, prediabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016-2017”. BMJ Open 8 (2018): e02096.
49. Baldé N-M., et al. “Diabetes and Impaired Fasting Glucose in Rural and Urban Populations in Futa Jallon (Guinea): Prevalence and Associated Risk Factors”. Diabetes and Metabolism 33 (2007): 114-120.

Citation

Citation: Amani Kallel., et al. “Prevalence of Diabetes and Pre-Diabetes and Its Associated Risk Factors among the Tunisian Population: Results of the ATERA-Survey”.Acta Scientific Medical Sciences 8.12 (2024): 31-42.

Copyright

Copyright: © 2024 Amani Kallel., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.